XEOMIN 200 UNIT
INCOBOTULINUMTOXINA : 200 UNIT · DIN 02556227 · MERZ PHARMACEUTICALS GMBH
Health Canada status: APPROVED
What is XEOMIN?
XEOMIN 200 UNIT contains INCOBOTULINUMTOXINA : 200 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02556227, held by MERZ PHARMACEUTICALS GMBH, supplied as POWDER FOR SOLUTION for INTRAGLANDULAR ; INTRAMUSCULAR administration. Health Canada currently lists it as approved, status dated 17-Mar-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02556227 |
|---|---|
| Brand name | XEOMIN |
| Generic / active ingredient | INCOBOTULINUMTOXINA : 200 UNIT |
| Manufacturer | MERZ PHARMACEUTICALS GMBH |
| Strength | 200 UNIT |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAGLANDULAR ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | M03AX01 BOTULINUM TOXIN |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 17-Mar-2025 |
What can be used instead?
Other Canadian products sharing ATC code M03AX01 BOTULINUM TOXIN. 12 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BOTOX | 100 UNIT | POWDER FOR SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 01981501 |
| BOTOX | 200 UNIT | POWDER FOR SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 02531585 |
| BOTOX | 50 UNIT | POWDER FOR SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 02531577 |
| BOTOX COSMETIC | 100 UNIT | POWDER FOR SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 02243721 |
| DYSPORT AESTHETIC | Strength | Powder For Solution | IPSEN BIOPHARMACEUTICALS CANADA INC SUITE 500 5050 Satellite Drive Mississauga Ontario Canada L4W 0G1 | MARKETED | DIN 02387735 |
| DYSPORT THERAPEUTIC | 300 UNIT | POWDER FOR SOLUTION | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED | DIN 02460203 |
| DYSPORT THERAPEUTIC | 500 UNIT | POWDER FOR SOLUTION | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED | DIN 02456117 |
| LETYBO | 100 UNIT | POWDER FOR SOLUTION | HUGEL CANADA INC. | MARKETED | DIN 02528142 |
| NUCEIVA | 100 UNIT | POWDER FOR SOLUTION | EVOLUS INCORPORATED | MARKETED | DIN 02480158 |
| XEOMIN | 100 UNIT | POWDER FOR SOLUTION | MERZ PHARMACEUTICALS GMBH | MARKETED | DIN 02324032 |
Who else supplies BOTULINUM TOXIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BOTULINUM TOXIN appears in 58 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.